BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31365694)

  • 21. Val66Met polymorphism and BDNF levels in Alzheimer's disease patients in North Indian population.
    Sonali N; Tripathi M; Sagar R; Vivekanandhan S
    Int J Neurosci; 2013 Jun; 123(6):409-16. PubMed ID: 23270505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BDNF Val66Met polymorphism, energy intake and BMI: a follow-up study in schoolchildren at risk of eating disorders.
    Arija V; Ferrer-Barcala M; Aranda N; Canals J
    BMC Public Health; 2010 Jun; 10():363. PubMed ID: 20573217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alzheimer's disease susceptibility genes modify the risk of Parkinson disease and Parkinson's disease-associated cognitive impairment.
    Fang L; Tang BS; Fan K; Wan CM; Yan XX; Guo JF
    Neurosci Lett; 2018 Jun; 677():55-59. PubMed ID: 29698690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphisms in Parkinson's disease and age of onset.
    Hong CJ; Liu HC; Liu TY; Lin CH; Cheng CY; Tsai SJ
    Neurosci Lett; 2003 Dec; 353(1):75-7. PubMed ID: 14642442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene polymorphisms and motor levodopa-induced complications in Parkinson's disease.
    Michałowska M; Chalimoniuk M; Jówko E; Przybylska I; Langfort J; Toczylowska B; Krygowska-Wajs A; Fiszer U
    Brain Behav; 2020 Mar; 10(3):e01537. PubMed ID: 32022467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Influence of BDNF Val66Met Polymorphism on Cognition, Cerebrospinal Fluid, and Neuroimaging Markers in Non-Demented Elderly.
    Xia H; Wang M; Li JQ; Tan CC; Cao XP; Tan L; Yu JT;
    J Alzheimers Dis; 2019; 68(1):405-414. PubMed ID: 30775992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of brain-derived neurotrophic factor (BDNF) Val66Met genetic polymorphism in bipolar disorder: a case-control study, comorbidities, and meta-analysis of 16,786 subjects.
    González-Castro TB; Nicolini H; Lanzagorta N; López-Narváez L; Genis A; Pool García S; Tovilla-Zárate CA
    Bipolar Disord; 2015 Feb; 17(1):27-38. PubMed ID: 25041243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity.
    Verhagen M; van der Meij A; van Deurzen PA; Janzing JG; Arias-Vásquez A; Buitelaar JK; Franke B
    Mol Psychiatry; 2010 Mar; 15(3):260-71. PubMed ID: 18852698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain-derived neurotrophic factor Val66Met polymorphism is associated with mild cognitive impairment in elderly patients with type 2 diabetes: a case-controlled study.
    Liu J; Yang W; Luo H; Ma Y; Zhao H; Dan X
    Aging Clin Exp Res; 2021 Jun; 33(6):1659-1666. PubMed ID: 32892314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A common polymorphism in the brain-derived neurotrophic factor gene in patients with adult-onset primary focal and segmental dystonia.
    Svetel MV; Djuric G; Novakovic I; Dobricic V; Stefanova E; Kresojevic N; Tomic A; Jankovic M; Petrovic I; Pekmezovic T; Kostic VS
    Acta Neurol Belg; 2013 Sep; 113(3):243-5. PubMed ID: 23381842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The relationship between the rs6265 polymorphism of the BDNF gene and the level of serum neurotrophic factor in patients with Parkinson's disease].
    Nikitina MA; Bragina EY; Nazarenko MS; Levchuk LA; Ivanova SA; Boiko AS; Gomboeva DE; Koroleva ES; Alifirova VM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(1):114-120. PubMed ID: 38261293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BDNF polymorphism associates with decline in set shifting in Parkinson's disease.
    van der Kolk NM; Speelman AD; van Nimwegen M; Kessels RP; IntHout J; Hakobjan M; Munneke M; Bloem BR; van de Warrenburg BP
    Neurobiol Aging; 2015 Mar; 36(3):1605.e1-6. PubMed ID: 25444596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations between brain-derived neurotrophic factor and cognitive impairment in panic disorder.
    Wang W; Liu Y; Luo S; Guo X; Luo X; Zhang Y
    Brain Behav; 2020 Dec; 10(12):e01885. PubMed ID: 33047489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain-derived neurotrophic factor (Val66Met) polymorphism and olfactory ability in young adults.
    Tonacci A; Borghini A; Mercuri A; Pioggia G; Andreassi MG
    J Biomed Sci; 2013 Aug; 20(1):57. PubMed ID: 23924085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BDNF Val66Met and cognition: all, none, or some? A meta-analysis of the genetic association.
    Mandelman SD; Grigorenko EL
    Genes Brain Behav; 2012 Mar; 11(2):127-36. PubMed ID: 21980924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain derived neurotrophic factor Val66Met polymorphism and psychotic symptoms in Alzheimer's disease.
    Pivac N; Nikolac M; Nedic G; Mustapic M; Borovecki F; Hajnsek S; Presecki P; Pavlovic M; Mimica N; Muck Seler D
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):356-62. PubMed ID: 21044653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of the effect of brain-derived neurotrophic factor (BDNF) polymorphisms on the risk of late-onset Alzheimer's disease (AD) and quantitative measures of AD progression.
    Desai P; Nebes R; DeKosky ST; Kamboh MI
    Neurosci Lett; 2005 May; 379(3):229-34. PubMed ID: 15843069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BDNF Val66Met polymorphism in primary adult-onset dystonia: a case-control study and meta-analysis.
    Gómez-Garre P; Huertas-Fernández I; Cáceres-Redondo MT; Alonso-Canovas A; Bernal-Bernal I; Blanco-Ollero A; Bonilla-Toribio M; Burguera JA; Carballo M; Carrillo F; Catalán-Alonso MJ; Escamilla-Sevilla F; Espinosa-Rosso R; Fernández-Moreno MC; García-Caldentey J; García-Moreno JM; García-Ruiz PJ; Giacometti-Silveira S; Gutiérrez-García J; Jesús S; López-Valdés E; Martínez-Castrillo JC; Martínez-Torres I; Medialdea-Natera MP; Méndez-Lucena C; Mínguez-Castellanos A; Moya M; Ochoa-Sepulveda JJ; Ojea T; Rodríguez N; Sillero-Sánchez M; Vargas-González L; Mir P
    Mov Disord; 2014 Jul; 29(8):1083-6. PubMed ID: 24925604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain-derived neurotrophic factor (BDNF) genetic polymorphism greatly increases risk of leucine-rich repeat kinase 2 (LRRK2) for Parkinson's disease.
    Liu J; Zhou Y; Wang C; Wang T; Zheng Z; Chan P
    Parkinsonism Relat Disord; 2012 Feb; 18(2):140-3. PubMed ID: 21924942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of smoking on cognition and BDNF levels in a male Chinese population: relationship with BDNF Val66Met polymorphism.
    Xia H; Du X; Yin G; Zhang Y; Li X; Cai J; Huang X; Ning Y; Soares JC; Wu F; Zhang XY
    Sci Rep; 2019 Jan; 9(1):217. PubMed ID: 30659208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.